Fuji Film acquires Russian subsidiary

  • 20 January 2009

Fuji Film Corporation has acquired its Russian distributor of medical and imaging products.

The acquisition, carried out through its European local corporation, Fuji Film Europe GmbH, will see the company buy Fuji Film-RU (herefater, Fujifilm Russia), a Russian independent distributor of its medical and imaging products, from Marubeni Corporation.

The deal establishes a direct sale structure by turning an independent distributor into its own sbusidiary. Fuji Film will accelerate its business expansion in the Russian market.

Since its incoporation in 1993, Fujifilm Russia has established its customer base in Russia as a distributing company for imaging products such as photography related equipment and medical products. In particular, it has been creating new demand for digitalisation in medical diagnostic imaging.

In the future, under a direct sales structure, Fujifilm will strengthen its capabilities to provide total solutions including Fujifilm’s global strategic product, the Synapse2 medical-use picture archiving and communication system (PACS).

In addition, through marketing and sales activities, Fuji will push forward the expansion of its medical business in the healthcare market.

Link

http://www.fujifilm.com/

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

NHS national image-sharing platform hits ‘record usage’

NHS national image-sharing platform hits ‘record usage’

The Image Exchange Portal (IEP) is now being used to share as many as 500 images per second, according to technology supplier Sectra.
NHS trusts awarded £30m for new medical and research tech

NHS trusts awarded £30m for new medical and research tech

The NIHR has awarded 36 NHS organisations £30 million to fund new medical technology and research equipment.
‘Time released to care’ should not be the main measure of digital’s success

‘Time released to care’ should not be the main measure of digital’s success

There should be much greater focus on the ‘benefits realisation’ of digital projects in the NHS. But take care to avoid adding to clinicians’ risk…